Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

190 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Active, not recruiting

Vaccine Pandemic Preparedness Through Airway Immunology Characterization

NCT05921448

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • Copenhagen Hospital Biobank Unit, Department of Clinical Immunology, Rigshospitalet, Denmark Copenhagen, Denmark
  • Diagnostic Immunology, Department of Clinical Immunology, Rigshospitalet, Denmark Copenhagen, Denmark
  • Institute for Immunology and Microbiology (ISIM), Panum Institute, University of Copenhagen Copenhagen, Denmark
  • Department of Medicine, Section of Respiratory Medicine, Herlev and Gentofte Hospital Gentofte Municipality, Copenhagen, Denmark
View Trial Details
Active, not recruiting

Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection

NCT05110911

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • The Children's Hospital at Westmead Westmead, New South Wales, Australia
  • Queensland Children's Hospital Brisbane, Queensland, Australia
  • Women's and Children's Hospital Adelaide, South Australia, Australia
View Trial Details
Completed

Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults

NCT05875961

Conditions
Infection Viral, Infections, Influenza, Human, +5 more
Locations
  • Meridian Clinical Research Rockville, Maryland, United States
  • Meridian Clinical Research Lincoln, Nebraska, United States
  • Meridian Clinical Research Omaha, Nebraska, United States
  • West Visayas State University Medical Center Iloilo City, Philippines
View Trial Details
Completed

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

NCT07204964

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Canoga Park, California, United States
  • GSK Investigational Site Walnut Creek, California, United States
  • GSK Investigational Site Hialeah, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
View all 17 locations
View Trial Details
Completed

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

NCT06087640

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • 84046-Accel Research Sites - Birmingham Birmingham, Alabama, United States
  • 84075-Cullman Clinical Trials Cullman, Alabama, United States
  • 84112-DM Clinical Research - Phoenix Phoenix, Arizona, United States
  • 84114-Scottsdale Clinical Trials Scottsdale, Arizona, United States
View all 255 locations
View Trial Details

Related conditions